ACHC

Acadia HealthcareC

Nasdaq / Health Care Equipment & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$31.00

+20.5% vs current

Most likely

Base case

50%

Probability

Target price

$24.50

-4.8% vs current

B-

Bear case

25%

Probability

Target price

$18.00

-30.0% vs current

AI sentiment snapshot

Latest data as of 2026-04-29

AI commentary

News tone is mixed but not decisively bearish. The most relevant checked primary source on April 23, 2026 showed a CFO transition alongside guidance reaffirmation, which offsets some immediate concern [#PR-2026-04-23]. However, this scheduled follow-up run lands before checked primary evidence of the actual Q1 2026 earnings release, so earnings surprise data, analyst revision signals, and post-release market reaction are unavailable. Because the anchor price is from April 28, 2026, any move after the planned after-close release on April 29, 2026 is also outside the packet's price baseline. Social coverage was not provided, so conviction should stay moderate rather than upgraded.

RankAlpha Sentiment Codex - 2026-04-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-29eventQ1 2026 release is still the next real thesis checkHigh impact

As of April 29, 2026, Acadia had reaffirmed Q1 guidance for revenue of $820-$830 million, adjusted EBITDA of $130-$137 million, and adjusted EPS of $0.25-$0.30, and said it would issue Q1 results after the market close on April 29 with the call on April 30. In the checked primary sources, the earnings release itself was not yet available, so beat/miss data and the initial post-print reaction remain pending rather than proven evidence [#PR-2026-04-23].

2026-05-01catalystFinance-leadership turnover adds another execution credibility testMedium impact

Acadia disclosed that CFO Todd Young will leave on April 30, 2026 and former CFO David Duckworth will return as interim CFO effective May 1, 2026, while the search for a permanent CEO remains ongoing. The company also reaffirmed Q1 and full-year 2026 guidance, which limits immediate thesis deterioration, but the leadership churn raises the bar for clean Q1 communication and follow-through [#8-K-2026-04-23] [#PR-2026-04-23].

2026-12-31catalystBed-add and occupancy execution remains the main path to margin repairHigh impact

Acadia ended 2025 with 277 behavioral healthcare facilities and over 12,500 beds, after adding 1,089 licensed beds during the year [#10-K-2026-02-27]. Management's 2026 outlook still depends on converting added capacity into occupancy and earnings, with full-year guidance of $3.37-$3.45 billion of revenue and $575-$610 million of adjusted EBITDA, so sustained operating improvement is still a later-2026 execution story rather than a confirmed recovery [#PR-2026-02-25] [#PR-2026-04-23].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-04-29 • Updated nightlySource: Internal modelMethodology